These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21121646)

  • 1. Determination of exposure multiples of human metabolites for MIST assessment in preclinical safety species without using reference standards or radiolabeled compounds.
    Ma S; Li Z; Lee KJ; Chowdhury SK
    Chem Res Toxicol; 2010 Dec; 23(12):1871-3. PubMed ID: 21121646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed Matrix Method Provides A Reliable Metabolite Exposure Comparison for Assessment of Metabolites in Safety Testing (MIST).
    Takahashi RH; Khojasteh C; Wright M; Hop CECA; Ma S
    Drug Metab Lett; 2017 Nov; 11(1):21-28. PubMed ID: 28699487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
    Gao H; Deng S; Obach RS
    Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.
    Yang Y; Grubb MF; Luk CE; Humphreys WG; Josephs JL
    Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3245-51. PubMed ID: 22006386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detection.
    Yu C; Chen CL; Gorycki FL; Neiss TG
    Rapid Commun Mass Spectrom; 2007; 21(4):497-502. PubMed ID: 17221928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple liquid-liquid extraction with hexane for low-picogram determination of drugs and their metabolites in plasma by high-performance liquid chromatography with positive ion electrospray tandem mass spectrometry.
    Xia YQ; Whigan DB; Jemal M
    Rapid Commun Mass Spectrom; 1999; 13(15):1611-21. PubMed ID: 10421903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bio-generation of stable isotope labeled internal standards for absolute and relative quantitation of drug metabolites in plasma samples by LC-MS/MS.
    Li P; Gong Y; Lim HK; Jian W; Edom RW; Salter R; Silva J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():92-100. PubMed ID: 23562907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹³C labelled internal standards--a solution to minimize ion suppression effects in liquid chromatography-tandem mass spectrometry analyses of drugs in biological samples?
    Berg T; Strand DH
    J Chromatogr A; 2011 Dec; 1218(52):9366-74. PubMed ID: 22119139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of dextromethorphan, dextrorphan, and guaifenesin in human plasma using semi-automated liquid/liquid extraction and gradient liquid chromatography tandem mass spectrometry.
    Eichhold TH; McCauley-Myers DL; Khambe DA; Thompson GA; Hoke SH
    J Pharm Biomed Anal; 2007 Jan; 43(2):586-600. PubMed ID: 16930908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.
    Lim HK; Chen J; Cook K; Sensenhauser C; Silva J; Evans DC
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1295-311. PubMed ID: 18383206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments (metabolites in safety testing). II. Application to unstable metabolites.
    Gao H; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1290-6. PubMed ID: 22456937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing MIST (Metabolites in Safety Testing): bioanalytical approaches to address metabolite exposures in humans and animals.
    Gao H; Obach RS
    Curr Drug Metab; 2011 Jul; 12(6):578-86. PubMed ID: 21434861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data.
    Zhu P; Tong W; Alton K; Chowdhury S
    Anal Chem; 2009 Jul; 81(14):5910-7. PubMed ID: 19518135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment.
    Schadt S; Chen LZ; Bischoff D
    J Mass Spectrom; 2011 Dec; 46(12):1281-6. PubMed ID: 22223420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of human plasma as matrix for calibration standards in pre-clinical LC-MS/MS methods--a way to reduce animal use.
    Jacobson BM; Olsson A; Fakt C; Öhman D
    J Pharm Biomed Anal; 2011 Mar; 54(4):826-9. PubMed ID: 21131157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a LC-MS/MS method with electrospray ionization for determination of LASSBio-579 in rat plasma.
    Conrado DJ; Palma EC; Fraga CA; Barreiro EJ; Rates SM; Dalla Costa T
    J Pharm Biomed Anal; 2007 Jan; 43(2):677-82. PubMed ID: 16979864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.